Members

Financial and Governance Updates:

On September 8, 2025, the MediXall Group Inc filed the 10-Q report for Quarter ending September 30, 2024 for Q3, 2024 with the U.S. Securities and Exchange Commission. You can access and review this 10-Q by clicking this link: Inline Viewer: MediXall Group, Inc. 10-Q 2025-09-08

‍On June 5, 2025, the MediXall Group Inc filed the 10-Q report for Quarter ending June 30, 2024 for Q2, 2024 with the U.S. Securities and Exchange Commission. You can access and review this 10-Q by clicking this link: Inline Viewer: MediXall Group, Inc. 10-Q 2025-06-05

On May 19, 2025, the MediXall Group Inc filed the 10-Q report for Quarter ending March 31, 2024 for Q1, 2024 with the U.S. Securities and Exchange Commission. You can access and review this 10-Q by clicking this link: Inline Viewer: MediXall Group, Inc. 10-Q 2025-05-19

On April 23, 2025, the MediXall Group Inc filed an 8-K with the U.S. Securities and Exchange Commission regarding the Board of Directors restructuring. You can access and review this 8-K by clicking this link: Inline Viewer: MediXall Group, Inc. 8-K 2025-04-18
‍
‍On January 27, 2025, the MediXall Group Inc 10-K for 2023 was filed with the U.S. Securities and Exchange Commission. You can access and review this 10-K by clicking this link: Inline Viewer: MediXall Group, Inc. 10-K 2023-12-31

‍We are pleased to provide the following updates on recent developments and financial matters:

September 5, 2025

‍June 5, 2025

May 29, 2025

May 22, 2025

May 20, 2025

‍April 23, 2025

March 12, 2025

January 28, 2025
‍
January 27, 2025

‍December 31, 2024

‍